Dexcom | DXCM - Stammkapital





Stammkapital Veränderung Datum
Abbott USD 1.74B 2.94M 2026-03
Align Technology USD 71.62M 1000 2026-06
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Globus Medical USD 135.67M 611K 2026-03
Inogen USD 23K 0 2023-12
Insulet USD 69.35M 87K 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.71M 55K 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06
Solventum Corp USD 170.11M 3.42M 2026-06
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teleflex USD 44.26M 70K 2026-03
West Pharmaceutical Services USD 70.4M 500K 2026-06
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06